03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
More than a year ago, in June 2018, the Pennsylvania Department of Labor and Industry (DLI) proposed...
Read More >
The SEC has issued its final Regulation Best Interest (Reg BI), Form CRS Regulation, RIA Interpretat...
Read More >
Supreme Court Makes It Easier to Sue for Fiduciary Breach - A unanimous U.S. Supreme Court has jus...
Read More >
The National Labor Relations Board in recent weeks has continued to overturn Board decisions from Pr...
Read More >
The National Labor Relations Board (NLRB) has held that an employer did not violate the National Lab...
Read More >
Seyfarth Synopsis: On January 30, 2020, the Maryland General Assembly voted to override Governor Lar...
Read More >